For sepsis, the drugs don't work

被引：14

作者：

Boyd, Mark ^{[1
]}

机构：

[1] Univ New S Wales, Kirby Inst Infect & Immun Soc, Coogee, NSW 2034, Australia

来源：

LANCET INFECTIOUS DISEASES | 2012年 / 12卷 / 02期

关键词：

ANTIRETROVIRAL THERAPY; LIFE EXPECTANCY; INDIVIDUALS; COHORT;

D O I：

10.1016/S1473-3099(12)70020-8

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

引用

页码：89 / 89

页数：1

共 10 条

[1]

[Anonymous], 18 C RETR OPP INF BO

[2] Adverse effects of antiretroviral therapy [J].

Carr, A ;

Cooper, DA .

LANCET, 2000, 356 (9239) :1423-1430

[3] HIV disease progression in Australia in the time of combination antiretroviral therapies [J].

Correll, PK ;

Law, MG ;

McDonald, AM ;

Cooper, DA ;

Kaldor, JM .

MEDICAL JOURNAL OF AUSTRALIA, 1998, 169 (09) :469-472

[4]

Eron Jr JJ, 2011, LANCET INFECT DIS, DOI [10.1016/51473-3099(11)70196-7, DOI 10.1016/51473-3099(11)70196-7]

[5]

Hogg R, 2008, LANCET, V372, P293, DOI 10.1016/S0140-6736(08)61113-7

[6] Safety and efficacy of raltegravir-based versus efavirenz-based combination therapy in treatment-naive patients with HIV-1 infection: a multicentre, double-blind randomised controlled trial [J].

Lennox, Jeffrey L. ;

Dejesus, Edwin ;

Lazzarin, Adriano ;

Pollard, Richard B. ;

Ramalho Madruga, Jose Valdez ;

Berger, Daniel S. ;

Zhao, Jing ;

Xu, Xio ;

Williams-Diaz, Angela ;

Rodgers, Anthony J. ;

Barnard, Richard J. O. ;

Miller, Michael D. ;

DiNubile, Mark J. ;

Nguyen, Bach-Yen ;

Leavitt, Randi ;

Sklar, Peter .

LANCET, 2009, 374 (9692) :796-806

[7]

Sabin CA, 2008, LANCET, V371, P1417, DOI 10.1016/S0140-6736(08)60423-7

[8] Abacavir-Lamivudine versus Tenofovir-Emtricitabine for Initial HIV-1 Therapy [J].

Sax, Paul E. ;

Tierney, Camlin ;

Collier, Ann C. ;

Fischl, Margaret A. ;

Mollan, Katie ;

Peeples, Lynne ;

Godfrey, Catherine ;

Jahed, Nasreen C. ;

Myers, Laurie ;

Katzenstein, David ;

Farajallah, Awny ;

Rooney, James F. ;

Ha, Belinda ;

Woodward, William C. ;

Koletar, Susan L. ;

Johnson, Victoria A. ;

Geiseler, P. Jan ;

Daar, Eric S. .

NEW ENGLAND JOURNAL OF MEDICINE, 2009, 361 (23) :2230-2240

[9] Once daily dolutegravir (S/GSK1349572) in combination therapy in antiretroviral-naive adults with HIV: planned interim 48 week results from SPRING-1, a dose-ranging, randomised, phase 2b trial [J].

van Lunzen, Jan ;

Maggiolo, Franco ;

Arribas, Jose R. ;

Rakhmanova, Aza ;

Yeni, Patrick ;

Young, Benjamin ;

Rockstroh, Juergen K. ;

Almond, Steve ;

Song, Ivy ;

Brothers, Cindy ;

Min, Sherene .

LANCET INFECTIOUS DISEASES, 2012, 12 (02) :111-118

[10] Life expectancy of recently diagnosed asymptomatic HIV-infected patients approaches that of uninfected individuals [J].

van Sighem, Ard ;

Gras, Luuk ;

Reiss, Peter ;

Brinkman, Kees ;

de Wolf, Frank .

AIDS, 2010, 24 (10) :1527-1535

← 1 →